We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Glycated Albumin Levels in Tears Allow Noninvasive Glucose Testing

By LabMedica International staff writers
Posted on 20 Oct 2020
Print article
Image: Glycated albumin levels in tears allows for noninvasive glucose testing (Photo courtesy of The University of Melbourne).
Image: Glycated albumin levels in tears allows for noninvasive glucose testing (Photo courtesy of The University of Melbourne).
The glucose test helps determine if a person’s glucose level is too high or too low, which can indicate the presence of Type 2 diabetes and other medical conditions. The two most common types of glucose testing are the fasting plasma glucose test and the random plasma glucose test.

Glycated albumin is albumin that has been glycated (bound to sugar). Albumin is the most common type of protein found in blood (~80% of circulating proteins) and is replaced in the body about every 20-25 days. Excessive glycation of albumin causes irreversible damage to organs and their vasculature.

Scientists at the University of Tokyo (Tokyo, Japan) recruited 100 adults (mean age, 50.87 years; 71% men) with diabetes from outpatient and inpatient practices. Participants had tear samples collected at the same time as a blood sampling tests. The team measured glycated albumin levels in tears with liquid chromatography-mass spectrometry, whereas blood sample levels were measured through an enzymatic method.

The investigators reported that glycated albumin levels were appropriately measured in 99 of 100 participants. Initial results showed a correlation between glycated albumin levels in blood and those measured in tears (beta = 0.722; 95% CI, 0.585-0.859). The correlation between tear levels and blood levels remained after adjustments for age, sex, nephropathy stage and obesity (beta = 0.738; 95% CI, 0.594-0.882). HbA1c was not assessed in the study.

Masakazu Aihara, MD, PhD, a project research associate and lead author of the study, said, “To achieve strict glucose control preventing diabetic complications, many patients take HbA1c tests in hospitals and some take self-monitoring of blood glucose. Continuous glucose monitoring has also been put into practical use, but all of these measurement methods are invasive, and it is a burden on the patients. We focus on tears, which can be collected with noninvasive ways, and found that the glycated albumin levels in tears and blood had strong correlation. Since glycated albumin reflects two week average blood glucose levels, it does not need to be measured as frequently as self-monitoring and can be used in the same way as HbA1c tests.”

Dr. Aihara added “The correlation of glycated albumin levels in tears and blood that we found in this study was much stronger than that of glucose levels, and a measurement method of tear glycated albumin can be used in clinical practice.” The study was presented at the European Association for the Study of Diabetes virtual meeting, held 21-25 September, 2020.

Related Links:
University of Tokyo

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1

Print article

Channels

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more